Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Blocking IL-17 signaling can delay skin aging and improve skin and hair health.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

Mesenchymal stem cell therapy may help treat alopecia areata by promoting hair growth and reducing inflammation.

Hydrogel composites have great potential in regenerative medicine, tissue engineering, and drug delivery.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

CD2 might be a new treatment target for patchy alopecia areata.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Many children with alopecia areata also have other autoimmune diseases.

Old drugs can be used for new treatments, saving time and money, but there are challenges like needing more evidence and legal concerns.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Generalized vitiligo in Chinese patients is linked to other autoimmune diseases, especially in familial cases.

Vitiligo is often found with other autoimmune diseases, which is important to know to help patients.

Alopecia areata is relatively common in children, has a variable course, and shows different responses to treatment; thyroid testing is recommended for those affected.

People with Alopecia Areata are more likely to have certain health issues like ulcerative colitis and type 1 diabetes, but less likely to have others like hypertension and type 2 diabetes.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Severe anti-TNF-α induced scalp eruptions often need stopping the drug and using systemic therapy to avoid scarring.

Type 1 diabetes patients often have other autoimmune diseases, which complicate their care.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Beau's lines and hair loss in a patient were linked to severe stress on the body.